Cargando…
Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation
Endostar, a novel recombinant human endostatin, which was approved by the Chinese State Food and Drug Administration in 2005, has a broad spectrum of activity against solid tumors. In this study, we aimed to determine whether the anticancer effect of Endostar is increased by using a nanocarrier syst...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000203/ https://www.ncbi.nlm.nih.gov/pubmed/21170352 http://dx.doi.org/10.2147/IJN.S14753 |